Salus Europe is the producer of best-in-class medical cannabis products
This is achieved through our expertise in the cannabis sector coupled with years of experience in the highly regulated pharmaceutical industry.
This is achieved through our expertise in the cannabis sector coupled with years of experience in the highly regulated pharmaceutical industry.
“Improving lives by providing patients with safe and consistent access to medical cannabis”
Alphafarma Operations Ltd. (MPXI-Malta) is an EU-GMP certified medical cannabis company that is rooted in MPXI’s years of experience developing leading cannabis operations and award-winning products across the medical cannabis field.
First Growth is a GACP licensed medical cannabis, greenhouse cultivation facility. It is predicated on high-quality cultivation to supply MPXI Malta with a consistent, cost-effective and high quality input.
Through our own genetics and collaboration with qualified suppliers, we are able to offer a diverse product portfolio capable of meeting various therapeutic needs.
Our state-of-the-art processing facility in Malta is guaranteed to produce products of the highest quality, safety and efficacy standards.
Our Management Team has more than 60 years combined experience leading established pharmaceutical manufacturing facilities that operate under strict EU-GMP regulations.
Salus Europe has distribution capabilities across Europe, thus guaranteeing access of medical cannabis products to patients where there is an established medical cannabis programme.